skip to content skip to nav

amfAR, The Foundation for AIDS Research

Research
Policy and Advocacy
TREAT Asia
Get Involved
About HIV/AIDS
About amfAR
Shop
For the Press

print |
email |
share

Overview
Grants
Countdown to a Cure for AIDS
amfAR Institute for HIV Cure Research
amfAR Research Consortium on HIV Eradication: (ARCHE)
Publications
Videos
Scientific Advisory Committee
Staff
Archive

Research Archive

Articles

2021

Defining Targets for Eradicating Latent HIV Reservoirs
Shock-and-Kill Trial Falls Short
Researchers Report Potential New Case of HIV Cure
A Pathway to Controlling Inflammation?
When U.S.-Based Studies Don’t Measure Up
The Not-So-Latent Reservoir
Tracing the Unique Immune Footprints of Elite Controllers
Can Long-Term Treatment Lead to ART-Free Control of HIV
Stem Cell Transplants and the CCR5 Mutation
Researchers Report New Case of Spontaneous HIV Cure
Keeping Dormant HIV Dormant
Why Do Some Elite Controllers Stop Controlling HIV?
Another HIV Vaccine Failure – What HIV and COVID Can Teach Each Other
A Promising, “Unusual” Approach to Targeting HIV Spike Protein
Do Sex Differences Matter for HIV Cure?
amfAR Grants Explore Gene Therapy Approaches to HIV Cure
UNAIDS: People Living With HIV More Vulnerable to COVID
Predicting Post-Treatment Control Before It Happens
Participants Sought for HIV-COVID-19 Study
Mimicking CD4: A Bait and Switch Approach to Immunotherapy
CAR Cells, Revved Up
HIV Research: Paving the Way to COVID Vaccines
Reversing HIV Latency and Decreasing the Viral Reservoir: Clues from Cancer
amfAR Announces 2021 Mathilde Krim Fellowship Recipients
Risks and Potential Benefits of Participating in Cure Research
Immunotherapy Targeting HIV Reservoirs
Participants Sought for COVID-19 Vaccine Follow-Up Study
New amfAR Grants Target Intersection of HIV and COVID-19
Verifying Models and Identifying New Targets for Attacking HIV Latency

2020

HIV Study Among Top Ten Breakthroughs of 2020
Prospects for an HIV/AIDS Cure: Opinions of People with HIV and Their Healthcare Providers
amfAR Partners with CytoDyn to Expand HIV Cure Strategy
Meet the Scientists - 2020
What Are the COVID Risks for People Living with HIV?
amfAR Invests in Next Generation HIV Cure Intervention
Mining the Blood for Markers of the Reservoir
HIV Reservoirs in the Blood and Gut Respond Differently to Virus Activators
The Past, Present, and Future of HIV Reservoir Cells
Molecular Pathways to an HIV Cure
Launching an HIV Trial in the Time of COVID-19
New Study Takes Deep Dive into Elite Control
Pioneering Clinical Trial Gets Underway
Victory for AIDS Activists over Vaccine Trial Exclusion
Exploring Cell Proteins That Block HIV
amfAR, Fashion, Fine Art: Pulling Together for COVID-19 Research
How Does the Immune System Recover After a Stem Cell Transplant?
UNAIDS Warns 2020 Targets Out of Reach
Cure Research Highlights at AIDS 2020
Case of São Paulo Patient Sparks Interest
A Tale of Two Viruses: HIV Researcher Joins Fight Against COVID-19
Why Do HIV Reservoirs Persist After Stem Cell Transplants?
COVID-19: Respiratory Distress and the Overactive Immune Response
When Treatment Stops, Why Can’t the Immune System Suppress HIV?
Deploying Data Against HIV and COVID-19
Does ART Adequately Reach Tissue Reservoirs of HIV?
Shape-Shifting Viral Proteins: Key to HIV and COVID-19 Vaccines
The Reservoir in Ultra High Res
Update on HIV Drugs and COVID-19
The London Patient - 30 Months Free of HIV
Probing the Provirus
Will HIV Drugs Help Fight Coronavirus?
New Methods to Reverse HIV Latency
Biomarkers May Point to Post-Treatment Control
Cost of HIV Treatment Rising
Can HIV Drugs Combat Coronavirus?

2019

Uncovering Novel Anti-HIV Factors
Uncovering an Early Marker for HIV Reactivation
amfAR Awards Support Promising Young HIV Researchers
Moving Closer to a Cure - Reduce and Control Strategies
Deploying New Imaging Techniques for HIV
2019 HIV CURE SUMMIT
Designing New Inhibitors of HIV Infection
New amfAR Grants Advance HIV Cure and Post-Treatment Control Studies
Former Krim Fellow Wins Prestigious NIH Award
Designing a Better Model for HIV Infection
amfAR Second Largest Funder of HIV Cure Research Worldwide
How HIV Hijacks Cell Machinery
amfARs Dr Rowena Johnston featured in IAS In the Studio
The Future of the HIV Response (Press Release)
Mapping an HIV Vaccine Target
Combination Treatment Cures Mice of HIV
A Biomarker for the Active HIV Reservoir?
Could Gene Therapy Cure HIV?
Non-AIDS Defining Illnesses Impact Health in the Age of ART
The Ability to Control HIV Without ART Runs in Families
amfAR Advances Collaborative Bioengineering Studies Aimed at Curing HIV
HIV Treatment Interruption - Lessons and Limitations
Semen May Facilitate HIV Transmission
First Living Kidney Donation From HIV-Positive Donor
What Stem Cell Transplants Can Teach Us About Curing HIV
A New Way to Overcome HIV Latency
amfAR RESEARCHERS UNABLE TO FIND HIV IN LONDON TRANSPLANT PATIENT(1)
amfAR RESEARCHERS UNABLE TO FIND HIV IN LONDON TRANSPLANT PATIENT
Fishing for New Ways to Overcome HIV Latency
Cycle 65 Grantees and Their Research Projects
New amfAR Grants Address HIV Cure Research Questions
Why Are Some T Cells Especially Prone to HIV Infection?

2018

Stem Cell Transplant Study: Researchers Report Drastic Reduction in HIV Reservoir
Gut vs. Blood: Deeper States of HIV Latency
amfAR Announces 2018 Mathilde Krim Fellowship Recipient
amfAR Awards New Funding for Gene Therapy Study Aimed at Curing HIV
A Novel “Kick and Kill” Strategy to Eliminate HIV
UCSF Loses a Revered HIV Scientist
Training a Person’s Own T Cells to More Effectively Kill HIV
The Mathilde Krim Effect
At the Crossroads of Research and Community: An Interview with Dr. Judd Hultquist
The Rich Dividends of HIV Research
The CHAMP Study - Clues to Natural Control of HIV Infection
Potential New Targets to Block HIV Latency
Sex and the HIV Reservoir
The CD8 T Cell in HIV - New Insights from Tissue vs Blood
amfAR Institute Administrator Recognized for Outstanding Contributions to HIV Research
Experimental Vaccine Neutralizes Dozens of HIV Strains
A New Source of Latent HIV?
Where Are We in HIV Vaccine Research?
Neutrophils: A Deadly, if Delicate, Killer
HIV in the Brain
Gutting HIV
New Findings Point to Power of Antibodies
Can the Berlin Patient’s Cure Be Replicated?
A Potential New Target for Eradication of HIV Reservoirs
Lab Chat: An Interview with Dr. Jonah Sacha
Progress Toward a Better “Shock and Kill”?
Experimental Flu Treatment an Outgrowth of HIV Research
amfAR Renews Investment in Bioengineering Approaches to Curing HIV
amfAR Salutes Women in HIV Research
Transmitting HIV (in the Test Tube) Despite Antiretroviral Therapy
Cancer Gene Therapy Strategy Suppresses HIV in Lab Study
Novel Methods to Eradicate HIV Reservoirs
Cancer Drug Leads to ‘Drastic Decrease’ of HIV Reservoir in Patient
amfAR-Funded Researchers Look to Antibodies to Cure HIV

2017

A New Model to Explore Stem Cell Transplantation Approaches to an HIV Cure
Closing in on HIV Eradication
How HIV Establishes Its Reservoirs
Novel Compound Suppresses HIV, Delays Viral Rebound
Scientists Identify HIV's 'Hiding Place'
New amfAR Awards Give Boost to Promising Young HIV/AIDS Researchers
The 2017 Mathilde Krim Fellowships in Basic Biomedical Research Grants
Lab Chat: An Interview with Dr. Shomyseh Sanjabi
Combination Antibody Strategy Shows Promise for HIV Cure
Using Groundbreaking CAR-T Cancer Therapy to Eliminate HIV
Starting, Stopping ART Can Affect HIV Reservoirs
Injection of Specific Antibodies May Reduce HIV Viral Load
Understanding Exactly How the 'Berlin Patient' Was Cured
amfAR-Funded Researcher Honored
Study Affirms Preventive Effect of HIV Treatment
A Gene Therapy Revolution?
New amfAR Research Grants Advance Gene Therapy and Other Innovative Approaches to HIV Cure
ARCHE Gene Therapy Grants - July 2017
Innovation Grants - July 2017
Shocking Latent HIV, Enhancing Immune Defense with a Single Drug
Looking for a Needle in the Haystack
More ‘Shocks’ in Strategies to Kill Latent HIV
Gene-Editing Tool Reduces HIV in Infected Mice
HIV Does Early, Lasting Damage to Immune System
Using Mice to Detect 'Undetectable' HIV
In the Vanguard of Vaccine Research
Defective—But Still Dangerous
Dock and Block: Scientists Develop Technique that Makes Cells Resistant to HIV
Exploring the HIV Envelope in Pursuit of an HIV Vaccine
Rachel’s Journey - Rachel Rutishauser MD-PhD
A Marker of Latently Infected Cells?
Bone Marrow Transplant Patient Off ART for Nearly 10 Months Without HIV Rebound
Vaccine Therapy Could Help Control HIV in Some Patients
Aging with HIV: Concerns About Accelerated Heart Disease
New amfAR Grants Enlist Help of Bioengineers to Overcome Obstacles to Curing HIV
Could an Innovative Drug Combination Eliminate HIV?
Understanding the ‘Interferon Paradox:’ A Novel Approach to Eradicating HIV
New Research on HIV Antibodies Advances Search for Cure
Gene Therapy to Cure HIV: Where to from Here?
A New Approach to HIV Latency

2016

A New Take on an Old Vaccine Idea
Following HIV Reservoirs: Impact of ART and Its Timing
Advances in HIV Latency Leading to New Cure Approaches
Gene-Editing Technology: A Game Changer for HIV Cure Research?
New amfAR Grants Support Next Generation of Scientists Pursuing Innovative Solutions to HIV/AIDS
What to Look for in Assessing HIV Cure Stories in the Media
New Antibody Therapy Sends HIV-Like Infection Into Sustained Remission
Scientists Discover Innovative Technique to Wake Up Dormant HIV
More Than One Way to Activate a Virus
Wanted: Bioengineers to Cure HIV
Measuring the Size of the HIV Reservoir
Further Progress on Antibodies Holds Promise for Prevention and Cure
The Broad Benefits of AIDS Research
Funds Raised During Seventh Annual Kiehl’s LifeRide for amfAR Accelerate Research Efforts Toward HIV Cure
Shocking HIV Out of Hiding: How Are We Doing?
Countdown to a Cure Grants List
Can Cancer Treatments Pave the Way to a Cure for HIV?
Researchers Design Antibodies to Eradicate HIV
HIV Cure Research Roundup July 2016
New amfAR Grant Addresses Key Challenge in Cure Research
Update from generationCURE Grant Recipient
Antibodies as an Important Part of an HIV Cure Strategy
amfAR Research Funding Targets Biggest Roadblocks to HIV Cure
Krim Fellow Graduates to NIH Grant
Using Antibodies to Block Mother-to-Infant Transmission of HIV … and Develop a Cure?
RFP - Mathilde Krim Fellowships in Basic Biomedical Research
Breaking a Vicious Circle - Controlling HIV Reservoirs by Targeting Inflammation
A Family Interest in Curing HIV
Principal Investigators and Collaborating Institutions
An Exciting New Research Collaboration - the amfAR Institute for HIV Cure Research
Our Moonshot
Attacking HIV in the Gut
CTLs: Stormtroopers of the Immune System
Curing HIV: Moving Forward Faster
amfAR Institute for HIV Cure Research - The Work Ahead
The Science, and Ethics, of Stopping ART in Assessing Possible HIV Cures
New amfAR Grants Spur Innovative HIV Cure Research Collaborations
Reducing Viral Reservoirs with Immune-Based Therapy

2015

Progress, Plans, and the Prospects for a Cure
Breast Milk Yields Clues to Natural Inhibitors of HIV
amfAR Establishes San Francisco-Based Institute for HIV Cure Research
2015 HIV Cure Summit Speakers
A Prominent Role for Innate Immunity in Eradicating HIV
New amfAR Awards Accelerate Research Towards HIV Cure
2015 HIV Cure Summit & RSVP
Natural Killers Adapt
Taking Control of HIV
Cure Matters: Conversations with Leading HIV Researchers
Division or Multiplication: Exploring the Maintenance of the HIV Reservoir
Request for Proposals: Innovation Grants
Release the Brake to Make HIV Go
Stabilize or Stimulate? A New Approach to Attacking the HIV Reservoir
Post-Treatment Controllers: Pathway to a Functional Cure?
A Rising Star in AIDS Research
One Cure May Not Fit All
New amfAR Grants Accelerate Research Efforts to Eradicate HIV
Are Early Immune Defenses Helping HIV Flourish?
To Reverse HIV Latency, Two Drugs Are Better Than One
Exposing HIV-Infected Cells to Antibody Attack
Request for Proposals: Investment Grants — Exploring HIV persistence and eradication
Rising to the Challenge: Questions for the Chairman of amfAR’s Scientific Advisory Committee
Better Tools Needed to Reach a Cure
generationCURE Awards Inaugural Cure-Focused Research Grant
Harnessing the Power of Antibodies
Beyond the Mississippi Baby
Mathilde Krim Fellowships in Basic Biomedical Research
Self-Sustaining Reservoirs of HIV
Restricting HIV Reservoir Size: Lessons from Patients
amfAR Announces $100 Million Investment Strategy Aimed at Curing HIV
Boosting Killer T cells to Eliminate HIV Reservoirs
Modeling and Controlling HIV Reservoirs

2014

The Impact of Early Treatment on HIV Reservoirs in Children
Sizing Up the HIV Reservoir
Viral Reservoirs: How Low Must We Go? By Jeffrey Laurence, M.D.
Save the Date: amfAR HIV Cure Summit
Exploring the mechanisms for HIV persistence and the potential for HIV eradication
Innovative New Approaches to Designing HIV Vaccines
Videos: amfAR Scientists Discuss Their Cutting-Edge HIV Cure Research
Transcripts: amfAR Scientists Discuss Their Cutting-Edge HIV Cure Research
Unraveling the Mechanisms of Male-to-Female HIV Transmission
How Cells Resist HIV Infection: New Clues
Surprising New Development in Mississippi Child Case
HIV Cure Research Gains Momentum from New amfAR Funding
Possible New Use for an Old Antiviral Drug in Attacking Latent HIV
Additional Approaches to Attacking the HIV Reservoir
amfAR Announces New Round of Cure-Focused Research Grants
Mathilde Krim Fellowships in Basic Biomedical Research (Deadline: May 15, 2014)
Testing “Shock and Kill”
HIV in the Blood and Gut: Exploring the Differences
Cure Research Roundup
amfAR Intensifies Efforts to Find a Cure for HIV
New Cure-Focused Grants Total More Than $2.15 million
Killer Immunity and HIV Reservoirs
Pursuit of HIV Cure Gets Funding Boost from amfAR
New Clues to the Nature of HIV Reservoirs

2013

Cure Research Stories: The Top 13 in 2013
Building a Stronger HAART by Jeffrey Laurence, M.D.
New Developments in Case of Stem-Cell Transplant Patients
amfAR Awards Give Boost to Promising Young HIV/AIDS Researchers
New Benefits of Antiretroviral Therapy Uncovered
Attacking AIDS by Attacking Inflammation
Exploring New Cell Reservoirs for HIV
Request for Proposals: Targeted Biomedical Research - Exploring the mechanisms for HIV persistence and the potential for HIV eradication
Working Towards a Cure
Purging Reservoirs of HIV
Researcher Reports Two HIV Patients Showing No Signs of Virus in Wake of Stem-Cell Transplants
Thai Study Demonstrates Reduced Risk of HIV Infection in Injection Drug Users Taking PrEP
Multi-Targeted Approaches to an HIV Cure
Perfecting Gene-Based Therapies Targeting HIV
Perfecting Tools to Monitor HIV Viral Loads
Keeping Track of HIV Reservoirs
First Child Cured of HIV
Stopping HIV Using a Cocktail of Genes Rather than Drugs
amfAR Awards $1.4 Million in New Grants for HIV Cure Research
Controlling HIV After Stopping Antiretroviral Therapy
Ideas into Action amfAR Think Tanks Address Approaches to Curing AIDS

2012

New amfAR Grants Nurture Next Generation of AIDS Researchers
Increasing HIV Testing Among MSM in Africa
Valiant Efforts to Save HIV Research at NYU During Hurricane Sandy
Exploring Potential New Targets for Anti-HIV Drugs
Broad Benefits of AIDS Research: Potential Cures for Other Viral Infections?
amfAR Awards Three New ARCHE Grants for Cure Research
amfAR Announces New Round of Cure-Focused Research Grants
Defining HIV Reservoirs
Curing HIV: Lessons from and for Children
Entering Third Year, amfAR Consortium Gathers Momentum in Quest for HIV/AIDS Cure
The Ethics of New HIV Testing Methods
HIV in the Crosshairs
Homophobia and the Spread of HIV in South Africa
Destroying HIV Reservoirs
Leading the Charge in Cure Research
Stem Cells: A Potential Role in Curing HIV?
“Shock and Kill” Strategy Holds Promise in the Search for a Cure
Top 10 HIV-Related Research Stories of 2011
Adhering to HAART: Challenges for Immigrant Latinos

2011

Researchers Debate Best Path to AIDS Cure
Gender-Based Risks for HIV among Drug Users
Closing in on a Cure: amfAR Symposium Looks to Holy Grail of AIDS Research
New amfAR Research Awards Bolster Search for HIV Cure
New Insights Into Hidden Reservoirs for HIV Infection (November 2011)
Research Leaders Meet for HIV Cure Workshop
A New Type of Vaginal Microbicide (October 2011)
New Momentum for AIDS Research:The amfAR Interview with Anthony Fauci, M.D.
An Animal Model for a Functional Cure for AIDS (September 2011)
Does Cocaine Increase the Threat of HIV? (July 2011)
amfAR Consortium Helps Lead Efforts for HIV AIDS Cure
Bringing Science to Bear: Questions for Mathilde Krim, Ph.D. (June 2011)
As Cure Search Intensifies, Questions Arise (May 2011)
The Ethics of Universal HIV Screening (May 2011)
Investments in Young Researchers Pay Off (May 2011)
Can “Humanized” Mice Advance HIV Prevention? (April 2011)
Focusing on CD8: The “Other T Cell” in HIV Infection (March 2011)
ARCHE Researchers Prove the Value of Collaboration
In the Lab, Recreating HIV’s Hidden Reservoirs (February 2011)
Attention to Cure Research Expanding on Multiple Fronts (January 2010)
Homing In on the Hideouts of HIV (January 2011)

2010

Tetherin' HIV: amfAR Awards New Grants to Tie Up the Virus
The HIV “Elites:” Viral Controllers and Their Genes (December 2010)
amfAR Welcomes iPrEx Study Results, Calls for Additional Research and Demonstration Projects
The Search for a Cure—Why Now?
HIV vs. the Immune System: Early Viral Mutations May Hold Clues for Vaccine Development (November 2010)
The Changeable Fitness of HIV: Implications for Early Treatment (October 2010)
Gene Therapy and the Potential for an HIV Cure (September 2010)
The Promise and Challenges of Universal HIV Screening (August 2010)
Nature Article Highlights amfAR Cure Consortium
Heterosexual Anal Sex: Implications for HIV Prevention (July 2010)
New Research Funding for AIDS Initiative in New York
New Insights into Old HIV Drug Classes: Uncovering Novel HIV Inhibitors (June 2010)
Controlling HIV in the Brain (May 2010)
Keeping HIV Out of a Cell’s Nucleus (April 2010)
Reducing HIV Growth to Zero (March 2010)
Defining the Key Targets of HIV Infection (March 2010)
The Promise of PrEP: Using Antiretrovirals to Prevent HIV Infection (February 2010)
Surprising Keys to a New Anti-HIV Compound (January 2010)

2009

amfAR Launches Consortium for a Cure
Animal Model Enables Researchers to Track the Evolution of HIV (December 2009)
As Good as It Can Be: Optimizing HIV Treatment (November 2009)
Probing the Untapped Potential of Gene Therapy (November 2009)
HIV, HAART, and the Kidneys (November 2009)
In Search of a Cure: Working to Turn On HIV (October 2009)
Important Step Forward In HIV Vaccine Research (September 2009)
Money Boys and the Spread of HIV in China (September 2009)
Passing the Viral Baton (July 2009)
HIV, HAART, and the Heart (July 2009)
Eradicating HIV—amfAR-Funded Researchers Shed New Light on HIV Persistence (July 2009)
Studying and Stopping Rectal Transmission of HIV (June 2009)
Battling Taboos and Scientific Challenges of Rectal HIV Transmission (June 2009)
A Day in the Lab: Dr. Ivan D'Orso (June 2009)
amfAR Research Fellow Wins Retrovirology Prize (May 2009)
Optimizing Adherence in Adult Survivors of Childhood Sexual Abuse (May 2009)
Monkeying Around With Genes Leads to Effective Simian Model (April 2009)
Their First Year: Young amfAR Scientists Publish “Spectacular” Work (February 2009)
Learning to Silence HIV (January 2009)
Your Money or Your Life (January 2009)

Participate

Sign Up for Newsletters
Follow Us on Facebook
Follow Us on Twitter
Follow Us on Instagram
Follow Us on YouTube
Donate via AmazonSmile

e-news-research-signup

Sign Up Today!

Help Find A Cure - Donate

Donate Now

About amfAR
About HIV/AIDS
Financial Information
Donor Privacy Policy
Terms of Use
Sitemap
For the Press
Contact Us
Jobs at amfAR

© 2021 amfAR All Rights Reserved || amfAR's mission is to end the global AIDS epidemic through innovative research